C.M. Bidwell & Associates’s Teva Pharmaceuticals TEVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-75
| Closed | -$1K | – | 544 |
|
|
2020
Q3 | $1K | Buy |
+75
| New | +$1K | ﹤0.01% | 445 |
|
|
2018
Q3 | – | Sell |
-15,150
| Closed | -$368K | – | 455 |
|
|
2018
Q2 | $368K | Buy |
+15,150
| New | +$368K | 0.34% | 82 |
|
|
2016
Q4 | – | Sell |
-42,345
| Closed | -$1.95M | – | 305 |
|
|
2016
Q3 | $1.95M | Buy |
+42,345
| New | +$1.95M | 0.46% | 83 |
|
|
2015
Q3 | – | Sell |
-6,095
| Closed | -$360K | – | 278 |
|
|
2015
Q2 | $360K | Buy |
6,095
+30
| +0.5% | +$1.77K | 0.08% | 122 |
|
|
2015
Q1 | $378K | Sell |
6,065
-9,710
| -62% | -$605K | 0.08% | 107 |
|
|
2014
Q4 | $907K | Buy |
15,775
+5,005
| +46% | +$288K | 0.21% | 85 |
|
|
2014
Q3 | $579K | Buy |
10,770
+4,645
| +76% | +$250K | 0.14% | 96 |
|
|
2014
Q2 | $321K | Buy |
+6,125
| New | +$321K | 0.07% | 114 |
|